Clinical Trial Update: Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating imetelstat in pediatric patients with refractory or recurrent solid tumors or lymphoma has completed. The update indicates the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor
• Childhood Solid Tumor
• Lymphoma
• Lymphoproliferative Disorder
• Small Intestine Cancer

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: Children's Oncology Group | Conditions: Brain and Central Nervous System Tumors, Lymphoma | Phase 1 | Status: COMPLETED